Science

Yüksel Ürün: Bias Risk in Studies Comparing Trimodal Therapy and Radical Cystectomy

Yüksel Ürün/X

Jun 22, 2025, 05:46

Yüksel Ürün: Bias Risk in Studies Comparing Trimodal Therapy and Radical Cystectomy

Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a paper by Daniele Robesti et al. published in Critical Reviews in Oncology/Hematology:

“Most retrospective studies comparing trimodal therapy and radical cystectomy are at high risk of informative censoring a bias that can artificially favor one treatment over another.”

Title: Trimodal Treatment vs Radical Cystectomy for Muscle-invasive Bladder Cancer: the Neglected Impact of Informative Censoring. A Systematic Review and Meta-analysis

Authors: Daniele Robesti, Filippo Micheli, Shesh N Rai, Giuseppe Fallara, Andrea Gallina, Francesco Montorsi, Alberto Briganti, Nicola Fossati, Antoine G van der Heijden, Guillaume Ploussard, Bernard Malavaud, Alberto Martini

You can read the Full Article in Critical Reviews in Oncology/Hematology.

More posts featuring Yüksel Ürün.

Alberto Briganti Alberto Martini Andrea Gallina Antoine G. Van der Heijden Bernard Malavaud bladder cancer cancer Daniele Robesti Filippo Micheli Francesco Montorsi Giuseppe Fallara Guillaume Ploussard MIBC Nicola Fossati OncoDaily Oncology radical cystectomy Shesh N Rai Trimodal Treatment Yüksel Ürün

Cancer in Dogs: Common Types, Symptoms, Diagnosis, and Treatment

Cardio-Oncology in Focus: How Chemotherapy Can Harm Heart Health

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?